Incannex Healthcare Insider Trades

IXHL

Track insider trading activity from Incannex Healthcare executives and directors. See which insiders are buying and selling IXHL stock.

Trades Last 12 Months

All Insider Trades for Incannex Healthcare

Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Latham Joel CEO And President
Holding Value $60.9M 24,186,177 shares
Last Trade
Nov 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239M 22,608,692 shares
$10.57
$2.52
Widdows Peter Director
Holding Value $4.93M 1,957,803 shares
Last Trade
Nov 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8M 1,686,956 shares
$10.57
$2.52
Clark Robert Director
Holding Value $4.5M 1,786,956 shares
Last Trade
Nov 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8M 1,686,956 shares
$10.57
$2.52
Holding Value $6.19M 2,456,677 shares
Last Trade
Nov 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.8M 1,686,956 shares
$10.57
$2.52
Swan Joseph Cfo, Treasurer And Secretary
Holding Value $2.32M 921,358 shares
Last Trade
Nov 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.19M 869,565 shares
$10.57
$2.52
Valentine Troy Director
Holding Value $30.2M 12,001,858 shares
Last Trade
Nov 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119M 11,302,608 shares
$10.57
$2.52
Barbato Luigi M. Chief Medical Officer
Holding Value $253k 100,476 shares
Last Trade
Oct 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 100,476 shares
$2.32
$2.52

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up